Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 97.57
-1.48 (-1.49%)
At close: Sep 26, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 22.29 billion as of September 26, 2025. Its market cap has increased by 180.70% in one year.
Market Cap
22.29B
Enterprise Value
23.91B
Revenue
12.97B
Ranking
n/a
PE Ratio
26.82
Stock Price
97.57
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 22.29B, an increase of 212.00%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 22.29B | 43.25% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 143.69B |
| Abbott Laboratories (Pakistan) | 124.52B |
| Highnoon Laboratories | 60.96B |
| The Searle Company | 59.74B |
| AGP Limited | 55.85B |
| Shifa International Hospitals | 34.59B |
| Macter International | 17.78B |
| Ferozsons Laboratories | 17.48B |